CAM

Cormorant Asset Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 314.52%
This Quarter Est. Return
1 Year Est. Return
+314.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$21.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$33.1M
2
+$20M
3
+$7.6M
4
VYNE icon
VYNE Therapeutics
VYNE
+$2.26M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$1.97M

Top Sells

1
+$17.3M
2
+$16.5M
3
+$15.7M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$11.8M
5
JANX icon
Janux Therapeutics
JANX
+$11.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTSR
26
DELISTED
Metsera Inc
MTSR
$11.4M 0.85%
400,000
AARD
27
Aardvark Therapeutics
AARD
$215M
$10.8M 0.81%
800,189
AXSM icon
28
Axsome Therapeutics
AXSM
$7.04B
$10.4M 0.78%
100,000
-150,000
BIOA
29
BioAge Labs
BIOA
$280M
$8.84M 0.66%
2,140,605
-488,924
ENGN icon
30
enGene Holdings
ENGN
$437M
$8.46M 0.63%
2,323,595
MBX
31
MBX Biosciences
MBX
$1.11B
$7.99M 0.59%
700,000
CABA icon
32
Cabaletta Bio
CABA
$222M
$7.6M 0.57%
+5,000,000
ALMS
33
Alumis Inc
ALMS
$574M
$6.44M 0.48%
2,147,396
BMEA icon
34
Biomea Fusion
BMEA
$90.5M
$6.43M 0.48%
3,570,872
KRRO icon
35
Korro Bio
KRRO
$57.2M
$5.81M 0.43%
465,000
+84,697
PCVX icon
36
Vaxcyte
PCVX
$6.37B
$5.69M 0.42%
175,000
RNA icon
37
Avidity Biosciences
RNA
$10.7B
$5.68M 0.42%
200,000
-200,000
ELVN icon
38
Enliven Therapeutics
ELVN
$1.31B
$4.01M 0.3%
200,000
-50,000
STOK icon
39
Stoke Therapeutics
STOK
$1.51B
$2.88M 0.21%
254,161
KALA icon
40
KALA BIO
KALA
$4.96M
$2.87M 0.21%
603,027
VYNE icon
41
VYNE Therapeutics
VYNE
$12.4M
$2.26M 0.17%
+1,370,938
BHVN icon
42
Biohaven
BHVN
$1.1B
$141K 0.01%
10,000
PLRX icon
43
Pliant Therapeutics
PLRX
$103M
– –
-3,000,000
RYTM icon
44
Rhythm Pharmaceuticals
RYTM
$6.63B
– –
-150,000
OKUR
45
OnKure Therapeutics
OKUR
$42.4M
– –
-1,837,739
1
2